Yanina Grant Huerta is Chief Accounting Officer of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 33,454 shares of ATRA, which is worth approximately $460,327. The most recent transaction as insider was on Nov 17, 2025, when has been sold 1,804 shares (Common Stock) at a price of $13.19 per share, resulting in proceeds of $23,794. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.5K
5.12% 3M change
n/a 12M change
Total Value Held $460,327

Yanina Grant-Huerta Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2025
SELL
Open market or private sale
$23,794 $13.19 p/Share
1,804 Reduced 5.12%
33,454 Common Stock
Aug 18 2025
SELL
Open market or private sale
$21,002 $11.61 p/Share
1,809 Reduced 4.88%
35,258 Common Stock
May 16 2025
SELL
Open market or private sale
$14,993 $6.76 p/Share
2,218 Reduced 5.65%
37,067 Common Stock
YG

Yanina Grant Huerta

Chief Accounting Officer
Thousand Oaks, CA

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Track Activities on ATRA